GIM
IDXX icon

Glenmede Investment Management’s Idexx Laboratories IDXX Stock Holding History

Glenmede Investment Management’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$12M Sell
18,754
-1,124
-6% -$682K 0.06% 310
2025
Q2 		$10.7M Buy
+19,878
New +$9.51M 0.05% 342

Other funds holding IDXX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fundsmith LLP
Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return

Glenmede Investment Management's IDXX Position: Q3 2025 in Review

Glenmede Investment Management reduced its Idexx Laboratories (IDXX) stake by 5.7% in Q3 2025, selling an estimated $682K and leaving 18,754 shares worth $12M. The position accounts for 0.06% of the portfolio, ranked #310.

Glenmede Investment Management first reported a position in IDXX in Q2 2025 and has held it in 2 quarters since. 1,302 funds tracked by Wall St. Rank hold IDXX as of Q3 2025.

  • Glenmede Investment Management held 18,754 shares of Idexx Laboratories worth $12M as of Q3 2025.
  • Glenmede Investment Management sold 1,124 Idexx Laboratories shares in Q3 2025, an estimated $682K.
  • Idexx Laboratories made up 0.06% of Glenmede Investment Management's portfolio in Q3 2025, its #310 holding.
  • Glenmede Investment Management first reported a position in Idexx Laboratories in Q2 2025 and has held it in 2 quarters since.
  • 1,302 funds tracked by Wall St. Rank held Idexx Laboratories as of Q3 2025.

Based on Glenmede Investment Management's 13F filing for Q3 2025, filed 13 Nov 2025.